Australia markets closed

Alexion Pharmaceuticals, Inc. (ALXN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
164.30+6.76 (+4.29%)
As of 10:21AM EDT. Market open.
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
6,069,900
6,069,900
4,991,100
4,131,200
3,551,100
Cost of revenue
553,500
553,500
394,500
374,300
454,200
Gross profit
5,516,400
5,516,400
4,596,600
3,756,900
3,096,900
Operating expenses
Research development
1,002,900
1,002,900
886,000
730,400
878,400
Selling general and administrative
1,399,900
1,399,900
1,261,100
1,111,800
1,094,400
Total operating expenses
2,656,500
2,656,500
2,456,700
2,162,300
2,292,900
Operating income or loss
2,859,900
2,859,900
2,139,900
1,594,600
804,000
Interest expense
104,700
104,700
77,800
98,200
98,400
Total other income/expenses net
-2,186,200
-2,186,200
116,700
-1,254,200
-157,800
Income before tax
569,000
569,000
2,178,800
242,200
547,800
Income tax expense
-34,400
-34,400
-225,500
164,600
104,500
Income from continuing operations
603,400
603,400
2,404,300
77,600
443,300
Net income
603,400
603,400
2,404,300
77,600
443,300
Net income available to common shareholders
603,400
603,400
2,404,300
77,600
443,300
Basic EPS
-
-
10.77
0.35
1.98
Diluted EPS
-
-
10.70
0.35
1.97
Basic average shares
-
-
223,200
222,700
223,900
Diluted average shares
-
-
224,800
224,500
225,400
EBITDA
-
1,003,100
2,633,400
745,700
1,142,900